MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Pattern of MRI findings in ephedronic encephalopathy

    M. Okujava, F. Todua, M. Janelidze, I. Khatiashvili (Tbilisi, Georgia)

    Objective: Objective of  the study was to summarize the typical neuroradiological picture of ephedronic encephalopathy and its clinical correlates. Background: Methcathinone (Ephedrone, Jeff etc.) emerged as…
  • 2017 International Congress

    Onabotulinumtoxin A (Botox) displays superior activity to incobotulinumtoxinA (Xeomin) in multiple in vitro and in vivo assays

    D. Canty, L. Le, J. Wang, G. Nicholson, A. Brideau-Andersen, L. Steward, B. Jacky, R. Broide, M. Washburn, D. Rupp (Irvine, CA, USA)

    Objective: This study was conducted to assess in vivo and in vitro activity of 50 U, 100 U, and 200 U vials of incobotulinumtoxinA (Merz,…
  • 2017 International Congress

    Neuroprotective effects of antidepressant mirtazapine against dopaminergic neurodegeneration in cultured cells and in parkinsonian mice possibly by targeting astrocytes

    M. Asanuma, I. Miyazaki, R. Kikuoka, S. Murakami, N. Isooka, Y. Kitamura (Okayama, Japan)

    Objective: In this study, we examined neuroprotective effects of mirtazapine and involvement of astrocytes in the effects using primary cultured cells and parkinsonian mice. Background:…
  • 2017 International Congress

    Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage

    H. Murakami, M. Kezuka, R. Kon, M. Kawamura, K. Ono (Tokyo, Japan)

    Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…
  • 2017 International Congress

    Predictor of progressive mild cognitive impairment in patients with Parkinson’s disease.

    Y. Tajiri, K. Wada-Isoe, M. Hamada, M. Sawada, K. Nakashima (Yonago, Japan)

    Objective: To clarify clinical features of patients with progressive mild cognitive impairment patients (MCI) in Parkinson’s disease (PD-MCI). Background: Non-demented PD subjects have MCI and…
  • 2017 International Congress

    Subcortical involvement in body and mental action processing: an electrophysiological registration study

    M. De Letter, P. Santens, D. Van Roost, G. Strobbe, P. Van Mierlo, A. Aerts, A. Bruggeman, K. De Keyser (Ghent, Belgium)

    Objective: The current research project focusses on the electrophysiological registration of semantics (body versus mental action verbs) within the thalamus, subthalamic nucleus (STN) and the…
  • 2017 International Congress

    Motor resonance in Parkinson’s disease: Effects of observed actions on behaviour

    E. Poliakoff, J. Bek, S. Vogt, T. Crawford, E. Gowen (Manchester, United Kingdom)

    Objective: To investigate whether people with Parkinson’s disease (PD) exhibit motor resonance from observed human actions. Background: Seeing another person move can influence one’s own…
  • 2017 International Congress

    Consideration of the relationship between severity of Parkinson’s disease and cognitive function, depression, quality of life

    M. Saruwatari, M. Sagawa, A. Kumon, K. Hasegawa (Sagamihara, Japan)

    Objective: In this study, we aimed to clarify the relationship between PD severity and cognitive function, depression and quality of life. Background: We are continuing…
  • 2017 International Congress

    Interval from onset of Parkinson disease to onset of motor and non-motor complications in Leucine-rich repeat kinase 2 (LRRK2) G2019S positive versus matched PD controls

    S. Gunzler, D. Riley, A. Wilson-Delfosse, S. Chen, J. Mieyal, C. Tatsuoka (Cleveland, OH, USA)

    Objective: To compare the latency between onset of Parkinson disease (PD) symptoms and onset of motor and non-motor complications of PD, between G2019S LRRK2 mutation…
  • 2017 International Congress

    Genetic analysis of RAB39B mutations in early-onset and familial Parkinson’s Disease in a Taiwanese population.

    C.-H. Lin, H.-H. Lin, R.-M. Wu, H.-I. Lin (Taipei, Taiwan)

    Objective: To examine the genetic contribution of RAB39B to early-onset and familial PD in a Taiwanese population. Background: Loss of function mutations in RAB39B were…
  • « Previous Page
  • 1
  • …
  • 86
  • 87
  • 88
  • 89
  • 90
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley